<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20448" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diabetic Ulcer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Packer</surname>
            <given-names>Corrine F.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ali</surname>
            <given-names>Syed Awab</given-names>
          </name>
          <aff>Mohsin Hospital Qamar Sialvi Road Gujrat</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Manna </surname>
            <given-names>Biagio</given-names>
          </name>
          <aff>RWJUH/Barnabas Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Corrine Packer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Awab Ali declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Biagio Manna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20448.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Diabetes mellitus is a metabolic endocrine disorder due to an overall deficiency of insulin (Type 1) or defective insulin function (Type 2) which causes hyperglycemia. Type 1 diabetes which is usually seen in younger patients accounts for 5% to 10% of cases worldwide and is secondary to autoimmune destruction of B-islet cells of the pancreas. Type 2 diabetes accounts for 90% to 95% of cases worldwide and is due to genetic and environmental factors with resultant insulin resistance and pancreatic beta-cell dysfunction. Complications arising from hyperglycemia can either be macrovascular or microvascular. The macrovascular disease affects mainly the cardiovascular and cerebrovascular systems, and the microvascular disease includes nephropathy, retinopathy, and neuropathies. A debilitating complication of diabetes mellitus is diabetic ulcers, which leads to increased overall morbidity in patients. This complication may be prevented, as the inciting factor is most often minor trauma. Early identification of these cutaneous injuries also can lead to improved outcomes while decreasing the risk of progression. Patients with diabetes mellitus (type 1 or 2) have a total lifetime risk of a diabetic foot ulcer complication as high as 25%. This activity reviews the evaluation and management of diabetic ulcers and the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Recall the cause of diabetic ulcer.</p></list-item><list-item><p>Describe the stages of a diabetic foot.</p></list-item><list-item><p>Summarize the treatment of diabetic ulcer.</p></list-item><list-item><p>Outline the evaluation and management of diabetic ulcers and the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20448&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20448">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20448.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Diabetes mellitus is a metabolic endocrine disorder due to an overall deficiency of insulin (Type 1) or defective insulin function (Type 2) which causes hyperglycemia. Type 1 diabetes which is usually seen in younger patients accounts for 5% to 10% of cases worldwide and is secondary to the autoimmune destruction of insulin-producing B-islet cells of the pancreas which results in complete insulin deficiency.&#x000a0; Type 2 diabetes accounts for 90% to 95% of cases worldwide and is due to genetic and environmental factors with resultant insulin resistance and pancreatic beta-cell dysfunction causing relative insulin deficiency. This form of diabetes remains clinically inevident for many years. Although abnormal glucose metabolism which is associated with chronic hyperglycemia results in complications that can either be macrovascular or microvascular. The macrovascular disease affects mainly the cardiovascular and cerebrovascular systems, and the microvascular disease includes nephropathy, retinopathy, and neuropathies.</p>
        <p>A debilitating complication of diabetes mellitus is diabetic ulcers, which leads to increased overall morbidity in patients. This complication may be prevented, as the inciting factor is most often minor trauma. Early identification of these cutaneous injuries&#x000a0;also&#x000a0;can lead to improved outcomes while decreasing the risk of progression. Patients with diabetes mellitus (type 1 or 2) have a total lifetime risk of a&#x000a0;diabetic foot ulcer complication&#x000a0;as high as 25%.&#x000a0;&#x000a0;<xref ref-type="bibr" rid="article-20448.r1">[1]</xref></p>
      </sec>
      <sec id="article-20448.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><bold>The Six Stages of a Diabetic Foot</bold> as described by the 7th Practical Diabetes International Foot Conference&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1 -&#x000a0;Normal foot with no risk factors;</p>
          </list-item>
          <list-item>
            <p>Stage 2 - High-risk foot</p>
          </list-item>
          <list-item>
            <p>Stage 3 - Ulcerated foot</p>
          </list-item>
          <list-item>
            <p>Stage 4 - Cellulitic foot</p>
          </list-item>
          <list-item>
            <p>Stage 5 - Necrotic foot</p>
          </list-item>
          <list-item>
            <p>Stage 6 - Foot that cannot be rescued</p>
          </list-item>
        </list>
        <p>There are three types of diabetic foot ulcer described namely neuropathic, neuroischaemic, and ischaemic.<xref ref-type="bibr" rid="article-20448.r2">[2]</xref>&#x000a0;<xref ref-type="bibr" rid="article-20448.r3">[3]</xref>&#x000a0; Sensory neuropathy leads to the majority of ulcers as a result of minor trauma which is not perceived by the patient and further goes untreated as there are no associated pain symptoms unless there is a routine evaluation to assist in identification.&#x000a0;<xref ref-type="bibr" rid="article-20448.r4">[4]</xref> Myocardial infarction is one of the most significant events related to peripheral arterial disease increased risk of ischemia. However, ischemia leading to diabetic ulcers adds severe morbidity and health care cost as it can be a chronic complication which is difficult to treat as there is insufficient blood supply.</p>
        <p>
<bold>Major Risk Factors&#x000a0;<xref ref-type="bibr" rid="article-20448.r5">[5]</xref></bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Peripheral motor neuropathy: Abnormal foot anatomy and biomechanics, with clawing of&#x000a0;toes, high arch, and subluxed metatarsophalangeal joints, leading to excess pressure, callus formation, and ulcers</p>
          </list-item>
          <list-item>
            <p>Peripheral sensory neuropathy: Lack of protective sensation, leading to unattended minor injuries caused by excess pressure or mechanical or thermal injury</p>
          </list-item>
          <list-item>
            <p>Peripheral autonomic neuropathy: Deficient sweating leading to dry, cracking skin</p>
          </list-item>
          <list-item>
            <p>Neuro-osteoarthropathy deformities (i.e., Charcot disease) or limited joint mobility</p>
          </list-item>
          <list-item>
            <p>Abnormal anatomy and biomechanics, leading to excess pressure, especially in the midplantar area</p>
          </list-item>
          <list-item>
            <p>Vascular (arterial) insufficiency: Impaired tissue viability, wound healing, and delivery of neutrophils</p>
          </list-item>
          <list-item>
            <p>Hyperglycemia and other metabolic derangements: Impaired immunological (especially neutrophil) function and&#x000a0;wound healing and excess collagen cross-linking&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20448.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The pooled worldwide prevalence of diabetic foot ulceration was 6.3%. North America had the highest prevalence of 13%; Oceania had the lowest prevalence of 3%. The prevalence in Africa was 7.2% which was higher than Asia 5.5%. Diabetic foot ulceration was more prevalent in male patients with diabetes mellitus, 4.5%, than female patients, 3.5%. Patients with type 2 diabetes mellitus (T2DM)&#x000a0;had a higher prevalence of ulceration at 6.4%&#x000a0;compared to patients with type 1 diabetes mellitus (T1DM), 5.5%.&#x000a0;<xref ref-type="bibr" rid="article-20448.r6">[6]</xref><xref ref-type="bibr" rid="article-20448.r7">[7]</xref></p>
        <p>In a systematic review and meta-analysis by Zhang et al. published in 2016, patients with diabetic foot ulceration had the following characteristics: older age (61.7 plus or minus 3.7 versus 56.1 plus or minus 3.9), longer diabetic duration (11.3&#x000a0;plus or minus&#x000a0;2.5 versus 7.4&#x000a0;plus or minus&#x000a0;2.2), lower body mass Index (BMI, 23.8 &#x000b1; 1.7 versus 24.4&#x000a0;plus or minus&#x000a0;1.7), higher percentage of smokers (29.1%, 95%CI: 18.3% to 39.8% versus 17.4%, 95% CI: 12.4% to 22.4%), hypertension (63.4%, 95%CI: 49.4% to 88.3% versus 53.1%, 95%CI: 33.8% to 72.5%), and diabetic retinopathy (63.6%, 95%CI: 38.8% to 88.3%% versus 33.3%, 95%CI: 13.8% to 52.7%) than patients that did not develop diabetic foot ulceration.&#x000a0;</p>
      </sec>
      <sec id="article-20448.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Atherosclerosis and diabetic peripheral neuropathy are the two main causes leading to a complication of diabetes such as ulcers. Atherosclerosis leads to decreased blood flow in large and medium-sized vessels secondary&#x000a0;to thickening of capillary basement membrane, loss of elasticity, and deposition of lipids within the walls. Further arteriosclerosis leads to small vessel ischemia. Peripheral neuropathy affects the sensory, motor, and autonomic nervous system. There are multifactorial causes such as vascular disease occluding the vasa nervorum, endothelial dysfunction, chronic hyperosmolarity, and effects of increased sorbitol and fructose.&#x000a0;</p>
      </sec>
      <sec id="article-20448.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The evaluation of patients presenting with diabetic ulcers can be divided into a clinical and radiologic assessment.</p>
        <p>A clinically pertinent history of the type of diabetes, medication history, comorbidities, symptoms of peripheral neuropathy, and vascular insufficiency should be elucidated. Symptoms of neuropathy include hypoesthesia, hyperesthesia, paresthesia, dysesthesia, and radicular pain. Vascular insufficiency has varying presentations and most patients are asymptomatic. However, they can present with intermittent claudication, rest pain, and healing or non-healing ulcers.</p>
        <p>In the examination of the legs and foot, an inspection should be performed in a well-lit room with appropriate exposure. Proper documentation using descriptions of ulcer characteristics with size, depth, appearance, and location performed. Presence of discoloration, necrosis, or areas of drainage are signs of infection, and further care is required. Other abnormalities such as nail discoloration, callus formation, and deformities should be noted. Imbalance in the innervations of the foot muscles from neuropathic damage can lead to the development of common deformities seen in affected patients. Hyperextension of the metatarsal-phalangeal joint with interphalangeal or distal phalangeal joint flexion leads to hammer toe and claw toe deformities, respectively. Charcot arthropathy is a commonly seen deformity. Assessment of footwear is important as it can be a contributing factor to the development of foot ulceration. The presence of callus or nail abnormalities should be noted.&#x000a0;</p>
        <p>Examine the cardiovascular system, checking popliteal, posterior tibial, and dorsalis pedis pulse. Claudication, loss of hair, and the presence of pale, thin, shiny, or cool skin are physical findings suggestive of potential ischemia. If a vascular disease is a concern, the evaluator should measure the ankle-brachial index (ABI). ABIs can, however, be falsely elevated in&#x000a0;patients with diabetes mellitus due to calcification of vessels. More reliable methods of assessing the potential for healing foot ulcers in&#x000a0;patients with diabetes mellitus suspected of having peripheral ischemia involve systolic toe pressure measurements by photoplethysmography or measurement of distal transcutaneous oxygen tension.&#x000a0;</p>
      </sec>
      <sec id="article-20448.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Based on wound depth and necrotic tissue, diabetic ulcers can be classified by the Wagner ulcer classification system.&#x000a0;<xref ref-type="bibr" rid="article-20448.r8">[8]</xref><xref ref-type="bibr" rid="article-20448.r9">[9]</xref><xref ref-type="bibr" rid="article-20448.r10">[10]</xref></p>
        <p>
<bold>Wagner-Meggitt Classification of Diabetic Foot</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Grade 0 - Foot symptoms like pain, only</p>
          </list-item>
          <list-item>
            <p>Grade 1&#x000a0;-&#x000a0;Superficial ulcers involving skin and subcutaneous tissue</p>
          </list-item>
          <list-item>
            <p>Grade 2&#x000a0;-&#x000a0;Deep ulcers involving ligaments, muscles, tendons, etc</p>
          </list-item>
          <list-item>
            <p>Grade 3&#x000a0;-&#x000a0;Ulcer with bone involvement&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Grade 4&#x000a0;-&#x000a0;Forefoot gangrene</p>
          </list-item>
          <list-item>
            <p>Grade 5&#x000a0;-&#x000a0;Full-foot gangrene</p>
          </list-item>
        </list>
        <p>
<bold>CBC</bold>
</p>
        <p>
<bold>Serum Inflammatory Markers</bold>
</p>
        <p><bold>X-Ray/Ultrasound:&#x000a0;</bold>Performed for the detection of the spread of the lesion and soft tissue involvement.</p>
        <p><bold>MRI:&#x000a0;</bold>Radiologic evaluation involves plain radiographs in&#x000a0;two-thirds of the views assessing for deformity<bold>.</bold>If there is suspicion of osteomyelitis, tendonitis, or joint inflammation MRI imaging should be performed.</p>
        <p>
<bold>Probe-to-bone Test</bold>
</p>
        <p>
<bold>Monofilament Test</bold>
</p>
        <p><bold>Bone Scan:&#x000a0;</bold>Can identify the involvement of deep wounds.</p>
        <p><bold>Biopsy and Culture:&#x000a0;</bold>Specimen of bone and other tissue involved and histopathological examination is performed with the culture. This can also guide antibiotic treatment in case of a bacterial infection.</p>
      </sec>
      <sec id="article-20448.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Multimodal Diabetic Ulcer Management<xref ref-type="bibr" rid="article-20448.r11">[11]</xref><xref ref-type="bibr" rid="article-20448.r12">[12]</xref></bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Patient Education:</bold> Education on foot care, as well as control of blood sugar levels, should be performed early. This can also be done with the aid of diabetic educators and social workers.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Blood-Sugar Control:</bold> This is&#x000a0;managed using a team approach of primary care physician, podiatry, and vascular specialist and based on the severity of the disease and the patient&#x02019;s attitude toward medication, especially insulin.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Decreasing Pressure</bold>, preventing further or new trauma: Offloading pressure to the area can be done with crutches, wheelchairs, and casting. Ulcer healing is improved with total contact casting, irremovable cast walkers compared to removable cast walkers.&#x000a0;<xref ref-type="bibr" rid="article-20448.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Improve Peripheral Vascular Circulation:</bold> Antiplatelet agents are the initial drug therapy;&#x000a0;however, insufficiency requires surgical bypass.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Prevent or Control Infection:</bold> Systemic and source control is achieved using antibiotics and surgical debridement.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Topical Ulcer Care:</bold>&#x000a0; Principles of wound care include the use of topical agents with dressing and debridement. Shallow ulcers can be managed with occlusive and semi-occlusive dressings. A specialized dressing containing hyaluronic acid, collagen, and surgical intervention for debridement is usually required in full-thickness ulcers.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20448.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p><bold>Venous Ulcers:&#x000a0;</bold>It is caused by chronic elevation of venous pressure leading to incompetent valves. Venous blood from deep veins refluxes into superficial veins causing varicose veins and lower limb edema.Leakage of plasma proteins and leukocytes causing edema and free radical damage to the tissue resulting in ulcer formation. The most common locations are the pretibial area and above the medial malleolus. Usually, a shallow ulcer with irregular borders and overlying fibrinous exudate is present.</p>
          </list-item>
          <list-item>
            <p><bold>Diabetic Dermatopathy:&#x000a0;</bold>These are purplish, round asymptomatic lesions that usually occur in the lower extremities but can be present anywhere on the body of diabetic patients. These lesions usually require no intervention.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Malignancy:-</bold> Different malignancies can present as cutaneous ulcers but systemic signs and symptoms ( fever, weight loss, malaise, etc) are also usually present. The diagnosis can be confirmed by microscopic examination of the biopsy specimen.</p>
          </list-item>
          <list-item>
            <p><bold>Superficial Thrombophlebitis:&#x000a0;</bold>Characterized by pain, erythema, tenderness overlying inflamed and thrombosed superficial veins.</p>
          </list-item>
          <list-item>
            <p><bold>Leukocytoclastic Vasculitis:&#x000a0;</bold>Inflammation of blood vessels and surrounding tissues caused by the deposition of immune complexes.</p>
          </list-item>
          <list-item>
            <p><bold>Gouty Arthritis:&#x000a0;</bold>Monosodium urate crystal deposits in joints can result in inflammation, usually associated with hyperuricemia.</p>
          </list-item>
          <list-item>
            <p><bold>Infection:&#x000a0;</bold>Primary infectious ulcer results either by direct inoculation or systemic spread. Clinical features vary with the types of infection.</p>
          </list-item>
          <list-item>
            <p><bold>Sickle Cell Disease:&#x000a0;</bold>Sickle cell disease can result in painful leg ulcers commonly on medial and lateral malleoli.</p>
          </list-item>
          <list-item>
            <p><bold>Drugs:-</bold>Some drugs e.g, warfarin, heparin, hydroxyurea can result in ulcer formation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20448.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of diabetic ulcers is dependant on various factors such as strict diabetes control, patient education, a healthy lifestyle, and proper wound care. Poor blood supply, infection, prolonged duration, and recurrent ulcers are associated with poor prognosis. These prognostic indicators are utilized to take necessary interventions and precautionary measures to reduce the risk of severe complications such as osteomyelitis and amputation.<xref ref-type="bibr" rid="article-20448.r14">[14]</xref><xref ref-type="bibr" rid="article-20448.r15">[15]</xref></p>
      </sec>
      <sec id="article-20448.s11" sec-type="Complications">
        <title>Complications</title>
        <p>&#x000a0;Diabetic ulcers can lead to many complications and are responsible for hospitalizations and functional disabilities in diabetic patients.<xref ref-type="bibr" rid="article-20448.r16">[16]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Gangrene</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Abscess</p>
          </list-item>
          <list-item>
            <p>Ascending lymphangitis</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
          <list-item>
            <p>Limb ischemia</p>
          </list-item>
          <list-item>
            <p>Amputation<xref ref-type="bibr" rid="article-20448.r17">[17]</xref><xref ref-type="bibr" rid="article-20448.r18">[18]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20448.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Proper debridement, wound irrigation and dressing care are necessary for the prevention of infection and healing. Off-loading in patients with diabetic foot ulcers by total contact casts and postoperative shoes is an effective measure for promoting wound healing. In diabetic patients, postoperative care is of even greater importance in the presence of various risk factors such as impaired mobility, decreased perfusion, malnutrition, and reduced sensation.<xref ref-type="bibr" rid="article-20448.r19">[19]</xref></p>
      </sec>
      <sec id="article-20448.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Early detection and treatment can help in decreasing complications. Timely interventions&#x000a0; and consultations with the following are recommended:<xref ref-type="bibr" rid="article-20448.r20">[20]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Endocrinologist</p>
          </list-item>
          <list-item>
            <p>Infectious disease specialist</p>
          </list-item>
          <list-item>
            <p>Vascular surgeon</p>
          </list-item>
          <list-item>
            <p>Podiatrist</p>
          </list-item>
          <list-item>
            <p>Orthopedic surgeon&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Plastic surgeon</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20448.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education about the proper care of wounds and the risk of recurrence is necessary to improve the quality of life of the patients. Reducing hospital visits and increasing the ulcer-free duration is the goal. Long term surveillance and information sharing can maximize the results of the care provided. Sharing articles written in plain and easy to understand language is the key to successful communication. Health care providers should be encouraged to provide necessary information available on various platforms.<xref ref-type="bibr" rid="article-20448.r21">[21]</xref></p>
      </sec>
      <sec id="article-20448.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Diabetes can lead to&#x000a0;serious&#x000a0;complications if they are not identified and managed adequately. Diabetic ulcers are a common complication of uncontrolled diabetes. The frequency of these complications can be lowered by controlling blood glucose, self-examination of feet, and regular check-ups by doctors.</p>
        <p>The following are some risk factors associated with diabetic foot ulcers:-</p>
        <list list-type="bullet">
          <list-item>
            <p>Abnormality of foot anatomy(e.g Charcot arthropathy)</p>
          </list-item>
          <list-item>
            <p>Poor&#x000a0;blood circulation(e.g weak pulse, cold skin, or blue skin)</p>
          </list-item>
          <list-item>
            <p>Abnormality of peripheral sensations(e.g inability to sense pain in diabetic neuropathy)</p>
          </list-item>
          <list-item>
            <p>Smoking can reduce circulation to the feet.</p>
          </list-item>
        </list>
        <p>Different&#x000a0;measures can be taken to reduce the risk of foot problems. In general, keeping blood glucose in the target range reduces all kinds of diabetic complications. This involves making a healthy diet and lifestyle changes. Avoiding activities associated with foot injuries and avoiding smoking can be helpful. Caring for nails and trimming them straight across to avoid skin injury. Washing feet and choosing socks and shoes wisely. Regular foot exams to avoid unnoticed injuries.<xref ref-type="bibr" rid="article-20448.r22">[22]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20448.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of a diabetic ulcer is very difficult and is best done with a team that includes an endocrinologist, surgeon, wound care nurse, internist, physical therapist, vascular surgeon, an infectious disease expert, and dietitian. Besides ensuring that glucose levels are controlled, one has to ensure that the tissue has an adequate blood supply. All diabetics should be urged to stop smoking and resume an exercise program. Close follow up is required by an interprofessional&#x000a0;team as these ulcers can rapidly lead to necrosis and loss of a digit or a limb. Diabetic ulcers and wounds should be evaluated by a standardized and evidence-based approach. Well established communication and coordination among the health providers can significantly decrease complications such as amputation.<xref ref-type="bibr" rid="article-20448.r23">[23]</xref><xref ref-type="bibr" rid="article-20448.r24">[24]</xref></p>
      </sec>
      <sec id="article-20448.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20448&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20448">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/diabetic-ulcer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20448">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20448/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20448">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-20448.s18">
        <fig id="article-20448.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Diabetic Ulcer
Due to neuropathy, vasculopathy, and foot deformity. 
Note periwound callous formation. Wagner Grade 2 Contributed by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Diabetic__Ulcerx__Neuropathy" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20448.s19">
        <fig id="article-20448.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Diabetic Foot Ulcer. Neuropathic ulceration in a patient with diabetes. Note periwound callous formation. Wagner Grade 2. Contributed by MA Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Diabetic__Foot__Ulcer" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-20448.s20">
        <fig id="article-20448.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Jodhpur&#x000a0;Technique. Depiction of success of the technique in a non-healing foot ulcer of a patient with diabetes with diabetic foot (diabetes controlled with HbA1C &#x0003c; 6.5 X one year). (A) Baseline multiple ulcers over the foot involving the heel and medial malleolus (pressure sites). The lesions are chronic non-healing ulcers (CNHUs) as they failed to heal despite multiple treatment sessions using collagen dressings, platelet-rich fibrin matrix (PRFM), hyperbaric oxygen as well as one flap transplant that necrosed within 4 weeks; and (B) Complete healing of ulcers can be appreciated after 3 months of&#x000a0;2 sessions of JT performed&#x000a0;1 month apart. Contributed by D Kachhawa, MD, and S Sonthalia, MD, DNB, MNAMS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Finalest__Figure__5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-20448.s21">
        <title>References</title>
        <ref id="article-20448.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulton</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Frykberg</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hellman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kirkman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lavery</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>LeMaster</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Sheehan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wukich</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.</article-title>
            <source>Phys Ther</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>88</volume>
            <issue>11</issue>
            <fpage>1436</fpage>
            <page-range>1436-43</page-range>
            <pub-id pub-id-type="pmid">19137633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edmonds</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doxford</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gough</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>New treatments in ulcer healing and wound infection.</article-title>
            <source>Diabetes Metab Res Rev</source>
            <year>2000</year>
            <season>Sep-Oct</season>
            <volume>16 Suppl 1</volume>
            <fpage>S51</fpage>
            <page-range>S51-4</page-range>
            <pub-id pub-id-type="pmid">11054889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNeely</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Boyko</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Ahroni</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Stensel</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Reiber</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Pecoraro</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?</article-title>
            <source>Diabetes Care</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-9</page-range>
            <pub-id pub-id-type="pmid">7729300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>U&#x000e7;kay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arag&#x000f3;n-S&#x000e1;nchez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lipsky</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Diabetic foot infections: what have we learned in the last 30 years?</article-title>
            <source>Int J Infect Dis</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>40</volume>
            <fpage>81</fpage>
            <page-range>81-91</page-range>
            <pub-id pub-id-type="pmid">26460089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gariani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>U&#x000e7;kay</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lipsky</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Managing diabetic foot infections: a review of the new guidelines.</article-title>
            <source>Acta Chir Belg</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-16</page-range>
            <pub-id pub-id-type="pmid">24720132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geraghty</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>LaPorta</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Current health and economic burden of chronic diabetic osteomyelitis.</article-title>
            <source>Expert Rev Pharmacoecon Outcomes Res</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>279</fpage>
            <page-range>279-286</page-range>
            <pub-id pub-id-type="pmid">30625012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Comparative efficacy of nine different dressings in healing diabetic foot ulcer: A Bayesian network analysis.</article-title>
            <source>J Diabetes</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>418</fpage>
            <page-range>418-426</page-range>
            <pub-id pub-id-type="pmid">30324760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gillibrand</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Management of diabetic foot ulcers in the community: an update.</article-title>
            <source>Br J Community Nurs</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>24</volume>
            <issue>Sup3</issue>
            <fpage>S14</fpage>
            <page-range>S14-S19</page-range>
            <pub-id pub-id-type="pmid">30817189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolton</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Managing Patients With Diabetic Foot Ulcers.</article-title>
            <source>Wounds</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>12</issue>
            <fpage>380</fpage>
            <page-range>380-381</page-range>
            <pub-id pub-id-type="pmid">30507549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parker</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Shuter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maresco-Pennisi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sargent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Finlayson</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Implementation of the Champions for Skin Integrity model to improve leg and foot ulcer care in the primary healthcare setting.</article-title>
            <source>J Clin Nurs</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>13-14</issue>
            <fpage>2517</fpage>
            <page-range>2517-2525</page-range>
            <pub-id pub-id-type="pmid">30791154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borys</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hohendorff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frankfurter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kiec-Wilk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Malecki</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Negative pressure wound therapy use in diabetic foot syndrome-from mechanisms of action to clinical practice.</article-title>
            <source>Eur J Clin Invest</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>e13067</fpage>
            <pub-id pub-id-type="pmid">30600541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giacomozzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sartor</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Telles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uccioli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sacco</surname>
                <given-names>ICN</given-names>
              </name>
            </person-group>
            <article-title>Ulcer-risk classification and plantar pressure distribution in patients with diabetic polyneuropathy: exploring the factors that can lead to foot ulceration.</article-title>
            <source>Ann Ist Super Sanita</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>284</fpage>
            <page-range>284-293</page-range>
            <pub-id pub-id-type="pmid">30575564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>2. Classification and Diagnosis of Diabetes: <italic>Standards of Medical Care in Diabetes-2018</italic>.</article-title>
            <source>Diabetes Care</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>Suppl 1</issue>
            <fpage>S13</fpage>
            <page-range>S13-S27</page-range>
            <pub-id pub-id-type="pmid">29222373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ndosi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wright-Hughes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Backhouse</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lipsky</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Bhogal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vowden</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jude</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Nixon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study.</article-title>
            <source>Diabet Med</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-88</page-range>
            <pub-id pub-id-type="pmid">29083500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apelqvist</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Agardh</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Long-term prognosis for diabetic patients with foot ulcers.</article-title>
            <source>J Intern Med</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>233</volume>
            <issue>6</issue>
            <fpage>485</fpage>
            <page-range>485-91</page-range>
            <pub-id pub-id-type="pmid">8501419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muduli</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>P P</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Behera</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Diabetic Foot Ulcer Complications and Its Management-a Medical College-Based Descriptive Study in Odisha, an Eastern State of India.</article-title>
            <source>Indian J Surg</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>Suppl 2</issue>
            <fpage>270</fpage>
            <page-range>270-4</page-range>
            <pub-id pub-id-type="pmid">26730008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulton</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Diabetic neuropathy and foot complications.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2014</year>
            <volume>126</volume>
            <fpage>97</fpage>
            <page-range>97-107</page-range>
            <pub-id pub-id-type="pmid">25410217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Megallaa</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Ismail</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zeitoun</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Khalifa</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes.</article-title>
            <source>Diabetes Metab Syndr</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>1287</fpage>
            <page-range>1287-1292</page-range>
            <pub-id pub-id-type="pmid">31336479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000e1;zaro-Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Arag&#x000f3;n-S&#x000e1;nchez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Morales</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial.</article-title>
            <source>Diabetes Care</source>
            <year>2014</year>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>789</fpage>
            <page-range>789-95</page-range>
            <pub-id pub-id-type="pmid">24130347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammendola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sacco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Butrico</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sammarco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Franciscis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serra</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The care of transmetatarsal amputation in diabetic foot gangrene.</article-title>
            <source>Int Wound J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-15</page-range>
            <pub-id pub-id-type="pmid">27696694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dorresteijn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kriegsman</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Assendelft</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Valk</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Patient education for preventing diabetic foot ulceration.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Dec</month>
            <day>16</day>
            <volume>2014</volume>
            <issue>12</issue>
            <fpage>CD001488</fpage>
            <pub-id pub-id-type="pmid">25514250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nather</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JLW</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Prevention of diabetic foot complications.</article-title>
            <source>Singapore Med J</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>291</fpage>
            <page-range>291-294</page-range>
            <pub-id pub-id-type="pmid">29974120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Reasonable Glycemic Control Would Help Wound Healing During the Treatment of Diabetic Foot Ulcers.</article-title>
            <source>Diabetes Ther</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>95</fpage>
            <page-range>95-105</page-range>
            <pub-id pub-id-type="pmid">30465160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20448.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Prevention and treatment of diabetic foot ulcers.</article-title>
            <source>J R Soc Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>104</fpage>
            <page-range>104-109</page-range>
            <pub-id pub-id-type="pmid">28116957</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
